Ansgar W. Lohse

Prof. Ansgar W. Lohse is Director of the I. Department of Medicine at the University Medical Center Hamburg-Eppendorf (UKE), specializing in Internal Medicine, Gastroenterology, and Hepatology. His work focuses on autoimmune liver diseases, viral hepatitis, and liver transplantation. He leads a research group investigating immunopathogenesis in chronic liver diseases and has contributed to clinical trials for novel therapies. Lohse is a member of major societies like EASL and DGIM.

Research interests include autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC), and SARS-CoV-2's impact on liver health. Notable achievements include defining histological criteria for AIH and advancing treatment strategies for cholangiocarcinoma. Awards include the Boehringer Ingelheim Preis and C.A. Ewald Förderpreis.

Recent articles highlight work on metabolomic biomarkers for hepatocellular carcinoma, immunotherapy safety in autoimmune liver diseases, and SARS-CoV-2 variant comparisons. Collaborates internationally through networks like the European Liquid Biopsy Society. Supervises studies on AIH quality of life and peer support programs.